| editorial | Q871232 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1092655566 |
| P356 | DOI | 10.1186/S13073-017-0489-Y |
| P2888 | exact match | https://scigraph.springernature.com/pub.10.1186/s13073-017-0489-y |
| P932 | PMC publication ID | 5683372 |
| P698 | PubMed publication ID | 29132412 |
| P50 | author | Cathryn Lewis | Q16731445 |
| Evangelos Vassos | Q21094949 | ||
| P2860 | cites work | Prediction of breast cancer risk based on profiling with common genetic variants | Q36583004 |
| Public knowledge of and attitudes toward genetics and genetic testing | Q36720757 | ||
| Polygenic transmission disequilibrium confirms that common and rare variation act additively to create risk for autism spectrum disorders. | Q38786077 | ||
| Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis | Q41392222 | ||
| Genome-wide association analysis identifies 30 new susceptibility loci for schizophrenia | Q47602743 | ||
| Multi-polygenic score approach to trait prediction | Q47750917 | ||
| Common alleles contribute to schizophrenia in CNV carriers | Q58131636 | ||
| Erratum: Common alleles contribute to schizophrenia in CNV carriers | Q60184485 | ||
| Biological insights from 108 schizophrenia-associated genetic loci | Q24561833 | ||
| An Examination of Polygenic Score Risk Prediction in Individuals With First-Episode Psychosis | Q34543157 | ||
| PRSice: Polygenic Risk Score software | Q35541148 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 96 | |
| P577 | publication date | 2017-11-13 | |
| P1433 | published in | Genome Medicine | Q15816848 |
| P1476 | title | Prospects for using risk scores in polygenic medicine | |
| P478 | volume | 9 |
| Q64087984 | A decade of Genome Medicine: toward precision medicine |
| Q89747545 | A polygenic predictor of treatment-resistant depression using whole exome sequencing and genome-wide genotyping |
| Q62737084 | An atlas of polygenic risk score associations to highlight putative causal relationships across the human phenome |
| Q60309353 | Atrial fibrillation genetic risk differentiates cardioembolic stroke from other stroke subtypes |
| Q57560926 | Complex genetics of female fertility |
| Q92555462 | Defining the Genetic, Genomic, Cellular, and Diagnostic Architectures of Psychiatric Disorders |
| Q60634032 | Evidence for increased genetic risk load for major depression in patients assigned to electroconvulsive therapy |
| Q97643246 | Genetic architecture of complex traits and disease risk predictors |
| Q101476410 | Genetic predictors of educational attainment and intelligence test performance predict voter turnout |
| Q89830292 | Genetics and major depressive disorder: clinical implications for disease risk, prognosis and treatment |
| Q57303386 | Genetics of self-reported risk-taking behaviour, trans-ethnic consistency and relevance to brain gene expression |
| Q97883650 | Impute.me: An Open-Source, Non-profit Tool for Using Data From Direct-to-Consumer Genetic Testing to Calculate and Interpret Polygenic Risk Scores |
| Q92074973 | Integration of genetic and clinical information to improve imputation of data missing from electronic health records |
| Q89655415 | Leveraging effect size distributions to improve polygenic risk scores derived from summary statistics of genome-wide association studies |
| Q92223365 | Migraine polygenic risk score associates with efficacy of migraine-specific drugs |
| Q88454830 | Neutral Theory, Disease Mutations, and Personal Exomes |
| Q58113261 | Polygenic Determinants for Subsequent Breast Cancer Risk in Survivors of Childhood Cancer: The St Jude Lifetime Cohort Study (SJLIFE) |
| Q100944029 | Polygenic prediction of PTSD trajectories in 9/11 responders |
| Q90303879 | Polygenic risk score identifies associations between sleep duration and diseases determined from an electronic medical record biobank |
| Q57303389 | Polygenic risk scores for major depressive disorder and neuroticism as predictors of antidepressant response: Meta-analysis of three treatment cohorts |
| Q58553352 | Polygenic risk scoring and prediction of mental health outcomes |
| Q63684034 | Potential use of clinical polygenic risk scores in psychiatry - ethical implications and communicating high polygenic risk |
| Q60622210 | Response to therapeutic sleep deprivation: a naturalistic study of clinical and genetic factors and post-treatment depressive symptom trajectory |
| Q64084584 | Selecting variants of unknown significance through network-based gene-association significantly improves risk prediction for disease-control cohorts |
| Q58594046 | Stem Cells, Genome Editing, and the Path to Translational Medicine |
| Q56516497 | Testicular Cancer in New Zealand (TCNZ) study: protocol for a national case-control study |
| Q61755960 | The Genetic Sphygmomanometer: an argument for routine genome-wide genotyping in the population and a new view on its use to inform clinical practice |
| Q89948704 | The multiplex model of the genetics of Alzheimer's disease |
| Q59543216 | The polygenic nature of telomere length and the anti-ageing properties of lithium. |
| Q47831206 | Translating neurogenomics: deconvoluting complex brain disorders. |
| Q91806246 | What is creating the height premium? New evidence from a Mendelian randomization analysis in China |
Search more.